Condition 1: Cerebral Palsy. Condition 2: Spastic diplegic cerebral palsy. Condition 3: Spastic quadriplegic cerebral palsy. Condition 4: Spastic hemiplegic cerebral palsy. Condition 5: Dyskinetic cerebral palsy. Condition 6: Ataxic cerebral palsy. Condition 7: Other cerebral palsy. Condition 8: Cerebral palsy, unspecified. Condition 9: Spastic diplegic cerebral palsy. Excl: hereditary spastic paraplegia Congenital spastic paralysis (cerebral) Spastic cerebral palsy NOS Spastic tetraplegic ce
Conditions
Interventions
Administration of 0.1 cc/Kg dose of Cerebrolysin IM injection to participants, 5 times a week for one month. Participants would give one month break without injection. For the third month, Cerebrolysi
Treatment - Drugs
Sponsors
Vice Chancellor for Reseach, Tehran university of medical sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria includes: 1. Participants must be 6 to 12 years old. 2. Participants must be free of grand mal seizure attacks. Exclusion criteria includes: 1. Participants with diagnosis of cerebral palsy and grand mal seizure attacks co-morbidity have been excluded of the study. 2. Participants with renal failure disorder would not be participated in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of improvement in spapsticity. Timepoint: Before intervention, At the end of the first month of treatment course, At the end of third month of second course of intervention. Method of measurement: Asworth Scoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElnaz Fattah Dizaji
Children's Medical Center
Outcome results
None listed